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Abstract
Cyhalothrin, a pyrethroid insecticide, induces stress-like symptoms, increases c-fos immunoreactivity in the paraventricular 
nucleus of the hypothalamus, and decreases innate immune responses in laboratory animals. Macrophages are key elements 
in cellular immune responses and operate at the tumor-host interface. This study investigated the relationship among cyhalo-
thrin effects on Ehrlich tumor growth, serum corticosterone levels and peritoneal macrophage activity in mice. Three experi-
ments were done with 10 experimental (single gavage administration of 3.0 mg/kg cyhalothrin daily for 7 days) and 10 control 
(single gavage administration of 1.0 mL/kg vehicle of cyhalothrin preparation daily for 7 days) isogenic BALB/c mice in each 
experiment. Cyhalothrin i) increased Ehrlich ascitic tumor growth after ip administration of 5.0 x 106 tumor cells, i.e., ascitic fluid 
volume (control = 1.97 ± 0.39 mL and experimental = 2.71 ± 0.92 mL; P < 0.05), concentration of tumor cells/mL in the ascitic 
fluid (control = 111.95 ± 16.73 x 106 and experimental = 144.60 ± 33.18 x 106; P < 0.05), and total number of tumor cells in the 
ascitic fluid (control = 226.91 ± 43.22 x 106 and experimental = 349.40 ± 106.38 x 106; P < 0.05); ii) increased serum corticos-
terone levels (control = 200.0 ± 48.3 ng/mL and experimental = 420.0 ± 75.5 ng/mL; P < 0.05), and iii) decreased the intensity 
of macrophage phagocytosis (control = 132.3 ± 19.7 and experimental = 116.2 ± 4.6; P < 0.05) and oxidative burst (control = 
173.7 ± 40.8 and experimental= 99.58 ± 41.7; P < 0.05) in vitro in the presence of Staphylococcus aureus. These data provide 
evidence that cyhalothrin simultaneously alters host resistance to Ehrlich tumor growth, hypothalamic-pituitary-adrenocortical 
(HPA) axis function, and peritoneal macrophage activity. The results are discussed in terms of data suggesting a link between 
stress, HPA axis activation and resistance to tumor growth.
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Experimental and epidemiological evidence shows the 
relevance of the interactions between stress and changes 
in immunity. A fixed-effect analysis showed that stress and 
depression are associated with i) overall leukocytosis, ii) 
mild reductions in absolute NK-cell counts and relative 
T-cell proportions, iii) marginal increases in CD4+/CD8+ 
ratios, and iv) moderate decreases in T-cell and NK-cell 
function (1). Changes in cell-mediated immune function 
and susceptibility to cancer were also reported in persons 
undergoing distressing life experiences (2,3). Accordingly, 
a variety of stressors have been found to alter immune 
responses in experimental animals. An inescapable foot 
shock and a psychological stressor generated with the 
use of a communication box were shown to concomitantly 
alter stress levels, macrophage activity, and Ehrlich tumor 
growth in mice (4); sound stress suppressed the T- and 
B-cell mediated responses in rats (5); inescapable foot 
shocks increased total alveolar cell count in OVA-sensitized 
rats (6); individual housing induced an altered immune-
endocrine response and, at the same time, decreased 
resistance to Ehrlich tumor growth (7); submissive mice 
displayed more anxiety-like behaviors and decreased 
macrophage activity, and showed a decrease in resistance 
to implantation and development of melanoma metastases 
in their lungs (8); stress induced by cohabitation with sick 
partners decreased macrophage activity (9) and dendritic 
cell phenotype (10). 
Pyrethroid insecticides that are widely used for their 
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activity against a broad spectrum of parasites have been 
reported to induce stress-like symptoms in laboratory 
animals (11-13). Thus, cyhalothrin (3.0 mg·kg-1·day-1 for 
7 days) induced no overt signs or symptoms of intoxi-
cation in rats, but did produce behavioral effects in the 
open field and plus-maze apparatuses similar to those 
induced by anxiogenic-like drugs such as picrotoxin (11). 
Further analysis of the effects of cyhalothrin showed that 
this pesticide increased serum corticosterone levels (11), 
decreased peritoneal macrophage activity in rats (14,15), 
and increased c-fos immunoreactivity in the paraventricular 
nucleus of the hypothalamus, but not in the basolateral 
amygdala of rats (16). 
Ehrlich tumor cells have been reported to elicit a strong 
host immune response (17,18), a fact that, together with 
other properties, makes this tumor an interesting model for 
analysis of the effects of drugs or external environmental 
agents on tumor growth. It has been reported that mac-
rophage activity modulates Ehrlich tumor growth (4,19). 
Thus, the purpose of the present study was to study the 
resistance of cyhalothrin-treated mice to Ehrlich tumor 
growth and to analyze the relationship between this effect 
and that induced by the pesticide on peritoneal macrophage 
activity. Serum corticosterone concentrations were also 
measured in the pesticide-treated mice. Studies in the field 
of psychoneuroimmunology show that susceptibility to, and 
recovery from infection, allergic reactions, tumor cell inocula-
tion, and autoimmune disorders are strongly influenced by 
nervous and endocrine system activity (20,21).
Material and Methods
Animals
Sixty male isogenic BALB/c mice from our own colony, 
weighing 30-40 g and about 90 days of age were used. 
The animals were housed under conditions of controlled 
temperature (22 ± 2°C), humidity (45-65%) and artificial 
light (12-h light/dark cycle, lights on at 7:00 am) with free 
access to rodent chow (Nuvital Company, Brazil) and wa-
ter. Sterilized and residue-free wood shavings were used 
as animal bedding. The experiments were performed in 
a similar, but separate room, to which the animals were 
transferred and kept in their home cages 7 days before the 
experiments. Animals were housed and used in accordance 
with the guidelines of the Committee on Care and Use of 
Laboratory Animal Resources of the School of Veterinary 
Medicine, University of São Paulo. These guidelines are 
similar to those of the NIH, USA.
Pesticide
A commercial formulation of cyhalothrin (Grenade®, Coo-
pers Schering Plough Animal Health, Brazil; 45 g/L, 92.7% 
purity of the active compound) was used. The formulation 
consists of four cyhalothrin isomers that comprise two pairs 
of enantiomers, A and B, in a 60:40 ratio, respectively; within 
each pair, the enantiomers are present in equal amounts. 
A 3.0-mg/kg dose of cyhalothrin present in the Grenade 
formulation was prepared in distilled water (3.0 mg/mL) and 
administered to the mice by gavage, once daily for 7 days. 
This formulation dose was chosen based on our previous 
studies suggesting that it produced no overt clinical signs 
or symptoms of intoxication but induced stress-like symp-
toms in rats (11), decreased macrophage and neutrophil 
activities (14,15) and increased c-fos immunoreactivity in 
the paraventricular nucleus of the rat hypothalamus (16). 
The LD50 calculated for mice of cyhalothrin present in this 
formulation was reported to be 37-62 mg/kg (22). The 
vehicle of cyhalothrin preparation employed in Grenade® 
(monylphenol ethoxylate, 9.5 EO (Renex®) plus calcium 
sulfonate and Arol 3700®), diluted in distilled water to the 
proper volume to be injected (1.0 mL/kg), was used as the 
control solution and administered by the same route and 
over the same time. Previous studies from our laboratory 
have shown no effects of Grenade’s vehicle on macrophage 
activity or behavior (14). 
Clinical observations
The observational grid proposed by Irwin (23) for 
toxicological screening was used. Control and cyhalothrin-
treated mice were observed daily (immediately after each 
cyhalothrin or control solution treatment) for the following 
overt signs and symptoms of intoxication: mortality, sedation, 
excitation, stereotypy, aggressiveness, piloerection, saliva-
tion, muscle tone, coarse tremors, convulsions, reactivity 
to touch, sleep, motor incoordination, gait, respiration, and 
quality of feces. Each symptom was assessed either by 
observing the spontaneous behavior of the mice in their 
home cages or by subjecting the animals to standardized 
manipulations such as bilateral pressure on their flanks 
(muscle tone). The animals of both groups were weighed 
immediately before the treatments on experimental days 
1, 3, 5, and 7.
Host resistance and Ehrlich tumor growth
Ehrlich tumor cells were obtained and analyzed as 
described by Matsuzaki et al. (24). Mice were inoculated 
intraperitoneally (ip) with 5.0 x 106 Ehrlich tumor cells with 
at least 90% viability. For Ehrlich tumor growth evaluation, 
experimental and control mice were deeply euthanatized 
under CO2, the ascitic fluid was collected, its volume was 
measured, and the number of tumor cells was counted in a 
Neubauer chamber. Tumor growth analysis was performed 
7 days after tumor cell inoculation. 
Collection of peritoneal macrophages
Macrophages were activated by an ip inoculation of 5.0 x 
106 Ehrlich tumor cells. Peritoneal macrophages were collect-
ed for analysis 24 h after tumor cell inoculation, as described 
elsewhere (25). Control mice were euthanatized under CO2 
and the peritoneal macrophages were obtained immediately 
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after by peritoneal lavage, using 5.0 mL phosphate-buffered 
saline (PBS), pH 7.2-7.4. The peritoneal fluid was collected 
into a plastic tube and kept in an ice bath. Macrophages were 
identified morphologically since they are smaller than Ehrlich 
tumor cells, being subsequently counted using a Neubauer 
chamber and Trypan blue dye. The number of cells was 
adjusted to 2.0 x 106 cells/mL. Only cell suspensions with 
90% or more viability were used. 
Measurement of peritoneal macrophage activity
A flow cytometer (Becton Dickinson Immunocytometry 
Systems, USA) interfaced with a Macintosh G4 computer 
was used to analyze peritoneal macrophage activity. Data 
from 10,000 events were collected in the list mode and 
analyzed with the Cell Quest Pro® software (Becton 
Dickinson Immunocytometry Systems). Cell populations 
were identified based on their properties on forward scat-
ter versus side scatter (FCSP/SCSP) plots, mechanically 
sorted and evaluated by light microscopy after Giemsa 
staining. Fluorescence data were collected on a log scale. 
Green fluorescence from 2’,7’-dichlorofluorescein diacetate 
(DCFH-DA, Molecular Probes, USA) was measured at 530 
± 30 nm (FL1 detector), and red fluorescence from pro-
pidium iodide (PI)-labeled Staphylococcus aureus (Sigma, 
USA) was measured at 585 ± 42 nm (FL2). PI and DCFH 
fluorescence was analyzed after compensation to correct 
for possible crossing-over between PI and DCFH signals.
Quantification of phagocytosis and oxidative burst 
was based on mean PI and DCFH fluorescence per cell, 
respectively. Briefly, 2 x 105 peritoneal cells (100 µL) were 
mixed with 200 µL 0.3 mM DCFH-DA in PBS and 100 µL of 
PI-labeled S. aureus in polypropylene tubes. Samples were 
incubated under agitation at 37°C for 30 min. The reactions 
were interrupted by the addition of 2 mL cold EDTA solution 
(3 mM) in order to block phagocytosis. After centrifugation 
at 250 g for 10 min, the cell pellets were resuspended in 1 
mL cold 3 mM EDTA for flow cytometry measurements. The 
mean fluorescence of green and red channels was taken as 
an indicator of oxidative burst and phagocytosis, respectively 
(26). Percent phagocytosis (percentage of peritoneal mac-
rophages that ingested bacteria) is reported as the number 
of peritoneal macrophages with red fluorescence divided 
by the total number of cells, multiplied by 100.
Corticosterone determination
Corticosterone was determined with commercial kits 
(Coat-A-Count, DPC®, USA). This procedure is based 
on a solid phase radioimmunoassay in which 125I-labeled 
corticosterone competes for a fixed time with the corticos-
terone present in the mouse samples for antibody sites. 
Serum samples were assayed directly without chemical 
extraction or purification. The limit of corticosterone detec-
tion was 16.45 nmol/L and the intra-assay and inter-assay 
coefficients of variation were 4.2 and 16.1%, respectively. 
In order to decrease data variability and the effects of cir-
cadian changes, control and experimental animals were 
intermixed for euthanasia and their blood was taken at the 
same time of day (between 8:00 and 10:00 am) 24 h after 
the last cyhalothrin or control solution treatment. 
Experimental design
Three independent experiments were carried out. In 
each two identical replicates were performed according to 
standard and quality assurance methods. The data obtained 
were pooled for statistical analysis and interpretation. 
In the first experiment, resistance to Ehrlich tumor 
growth was analyzed. Twenty mice were divided equally 
at random into an experimental group and a control group. 
Animals from both groups were treated by gavage with 
cyhalothrin (3 mg·kg-1·day-1; in a volume of 1 mL/kg) or 
with control solution (1.0 mL/kg) for 7 days, respectively. 
These animals, that were observed clinically for possible 
signs and symptoms of cyhalothrin intoxication, received ip 
5.0 x 106 Ehrlich tumor cells (at least 90% viability) on the 
first day of cyhalothrin treatment; 24 h after the last cyha-
lothrin treatment, i.e., 8 days after tumor cell inoculation, 
the animals were euthanatized under CO2 for tumor growth 
evaluation. Experiments 2 and 3 were designed to analyze 
the effects of cyhalothrin on macrophage activity after Ehrlich 
tumor cell inoculation and on serum corticosterone levels, 
respectively. In each experiment, 20 mice were divided at 
random into two equal groups, an experimental one and 
a control one. Animals from the experimental and control 
groups were treated with cyhalothrin or control solution as 
described in experiment 1. In experiment 2, control and 
experimental mice received ip 5.0 x 106 Ehrlich tumor cells 
(at least 90% viability) immediately after the last cyhalothrin 
or control solution treatment; macrophage activation, col-
lection and analysis were performed as described above, 
i.e., 24 h after tumor cell inoculation. In experiment 3, trunk 
blood was harvested from control and experimental mice 
24 h after the last cyhalothrin or control solution treatment 
for the determination of serum corticosterone levels.
Statistical analysis
Statistical analysis was performed using the StatPac Statis-
tic Analysis Package. The Bartlett test and Kolmogorov-Smirnov 
test were initially applied in order to determine whether the data 
should be analyzed by parametric or nonparametric tests. The 
Student t-test (unpaired, two-tailed) was then used to compare 
parametric data and the Mann-Whitney U-test was used to 
compare nonparametric data. The probability of P < 0.05 was 
considered to show significant differences for all comparisons 
made. Data are reported as means ± SD.
Results
Experiment 1. Effects of cyhalothrin on Ehrlich tumor 
growth
Administration of cyhalothrin (3.0 mg·kg-1·day-1, for 7 
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days) did not induce overt clinical signs and symptoms 
of intoxication in the mice. Indeed, no differences were 
found between experimental and control mice concerning 
body weight and the various other parameters included in 
the observational grid used to analyze toxicity (data not 
shown).
However, and as shown in Figure 1, cyhalothrin admin-
istration (3.0 mg·kg-1·day-1) for 7 days increased Ehrlich 
ascitic tumor growth (P < 0.05). In fact, although some 
overlaps in SD were observed, statistical analysis (Mann-
Whitney U-test) showed that treatment with this pyrethroid 
insecticide increased the volume of ascitic fluid (control 
= 1.97 ± 0.39 mL; experimental = 2.71 ± 0.92 mL, P < 
0.05), the concentration of tumor cells/mL of ascitic fluid 
(control = 111.95 ± 16.73; experimental = 144.60 ± 33.18, 
P < 0.05) and the total number of tumor cells found in this 
fluid (control = 226.91 ± 43.22; experimental = 349.40 ± 
106.38, P < 0.05).
Experiment 2. Effects of cyhalothrin on peritoneal 
macrophage activity 
Table 1 shows that no differences between experimental 
and control data were detected when the 
basal oxidative burst was measured in peri-
toneal macrophages taken 24 h after Ehrlich 
tumor cell inoculation. However, statistical 
analysis revealed differences between 
control and experimental data regarding the 
intensity of macrophage phagocytosis and 
macrophage oxidative burst in the presence 
of S. aureus in vitro. Specifically, peritoneal 
macrophages from cyhalothrin-treated mice 
presented a smaller intensity of in vitro S. 
aureus phagocytosis compared to control 
mice (P < 0.001; Mann-Whitney U-test). 
Accordingly, cyhalothrin treatment decreased macrophage 
oxidative burst compared to control (P < 0.001; Student 
t-test). No differences were found between control and 
experimental macrophage data for percent in vitro S. aureus 
phagocytosis (P > 0.05).
Experiment 3: Cyhalothrin effects on corticosterone 
serum levels
Biochemical analysis of serum corticosterone levels 
showed that cyhalothrin (3.0 mg·kg-1·day-1 for 7 days) in-
creased corticosterone levels compared to control (control 
= 200.00 ± 48.30; experimental = 420.35 ± 75.50, P < 0.05; 
Student t-test).
Discussion
Exposure to virtually any stressor activates the hypo-
thalamic-pituitary-adrenocortical (HPA) axis and results in 
a readily discernible elevation in plasma corticosterone 
levels. The present results showed an increase in serum 
corticosterone levels in mice treated with cyhalothrin (3.0 
mg/kg once daily for 7 days). Assessment of plasma corti-
costerone has been used as a reliable measure of stress 
(27). Thus, the present results agree with data previously 
reported for a similar cyhalothrin treatment in rats and also 
with data showing that it increased c-fos immunoreactivity 
in the paraventricular nucleus of the hypothalamus (16), an 
area tightly linked to HPA axis activation during stress (28). 
Thus, the present data agree with and support our previ-
ous suggestion of a stressor-like effect for this pyrethroid 
insecticide. Stress is defined here as a process by which 
an organism responds to challenging internal or external 
events (1). 
Cyhalothrin treatment (3.0 mg/kg once daily for 7 days) 
decreased mouse resistance to Ehrlich tumor growth as 
inferred by the increased volume of ascitic fluid, the total 
number of Ehrlich tumor cells and the concentration of 
Ehrlich tumor cells/mL of ascitic fluid found in the experimen-
tally treated mice after being injected with 105 tumor cells. 
Physical and psychological stressors have been reported to 
decrease resistance to Ehrlich tumor (4,7,9). A decreased 
resistance to mammary tumor growth and its response to 
Figure 1. Effects of cyhalothrin (3 mg·kg-1·day-1) for 7 days (black columns) on 
Ehrlich tumor growth. Control mice (gray columns) were injected with control solu-
tion (1.0 mL·kg-1·day-1 for 7 days). Mice received 5 x 106 Ehrlich tumor cells ip 
with the 1st treatment with cyhalothrin or control solution. A, Ascitic fluid volume; 
B, concentration of tumor cells/mL ascitic fluid; C, total number of tumor cells. Data 
are reported as means ± SD for N = 10 animals/group. *P < 0.05 compared to 
control (Mann-Whitney U-test).
Table 1. Effects of cyhalothrin (3 mg/kg for 7 days) on peritoneal 
macrophages activated by Ehrlich ascitic tumor cells in mice. 
Parameters Control Experimental
Oxidative burst
Basal 151.58 ± 56.39 130.41 ± 86.89
Staphylococcus aureus 173.70 ± 40.83 99.58 ± 41.72*
Phagocytosis
Intensity 132.29 ± 19.68 116.21 ± 4.60+
Percent (%) 68.86 ± 6.43 67.65 ± 9.47
Mice received 5 x 106 Ehrlich tumor cells ip on the 7th day of 
treatment with cyhalothrin or control solution. Macrophage activ-
ity was assessed 24 h later. Data are reported as means ± SD 
of fluorescence intensity unless otherwise indicated for N = 10 
animals/group. Control mice were injected with control solution 
(1.0 mL·kg-1·day-1 for 7 days). *P < 0.001 compared to control 
(Student t-test). +P < 0.001 compared to control (Mann-Whitney 
U-test).
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chemotherapy have also been reported in stressed mice 
(29). Submissive and socially stressed mice displayed more 
anxiety-like behaviors and showed a decreased resistance 
to the implantation and development of melanoma metas-
tases in their lungs (8). The present findings on Ehrlich 
tumor growth are thus consistent with previous reports 
from this and other laboratories showing that susceptibility 
to and recovery from infection, tumor cell inoculation, and 
autoimmune disorders are strongly influenced by states of 
central nervous system activation (2,10,30).
The development of the ascitic form of the Ehrlich tumor 
is tightly linked to the activity of the immune system (19) and 
particularly to the activation of resident macrophages (31). 
Indeed, macrophages are the prevalent mononuclear cell 
population that migrates to Ehrlich tumor focus where they 
operate at the tumor-host interface and modulate Ehrlich 
tumor growth (32). As a matter of fact, the macrophages 
analyzed here were collected from mice 24 h after Ehrlich 
tumor cells inoculation and it is known that stimulation of 
peritoneal macrophages by Ehrlich tumor cells occurs on 
the first 3 days after injection of tumor cells (19,23,32). 
Activated macrophages, which present a large number 
of morphologic, functional, and metabolic differences from 
resting cells (33), exhibited a high antitumor cytotoxic re-
sponse (34). The cyhalothrin treatment used in this experi-
ment (3.0 mg/kg once daily for 7 days) decreased peritoneal 
macrophage activity as inferred from data on both intensity of 
S. aureus phagocytosis (number of bacteria phagocytized) 
and S. aureus-induced oxidative burst. Increased phago-
cytosis and respiratory burst rates with the consequent 
generation and release of reactive oxygen intermediates 
such as H2O2, characterize macrophage activation (35). In 
this respect, the present results on Ehrlich tumor-activated 
macrophage phagocytosis in mice agree with and support 
those previously reported by our laboratory for onco BCG-
activated peritoneal macrophages in rats (15). Contrary to 
our previous data, no differences were found here in the 
effects of cyhalothrin on percent macrophage phagocyto-
sis (number of macrophages presenting phagocytosis). 
Differences in in vivo macrophage activation (onco BCG 
x tumor cells) and in the animals studied (rats and mice) 
might account for the differences observed.
An inverse correlation between peritoneal macrophage 
activity and resistance to Ehrlich tumor growth has already 
been reported in stressed mice (4,7). Other stressors sup-
pressed the antitumor activity of mononuclear phagocytes, 
leading to a decrease in host resistance to tumor challenges 
(4,8). Thus, it seems reasonable to suggest that the changes 
induced by cyhalothrin treatment (3.0 mg/kg once daily for 7 
days) in macrophage activity may account for the presently 
described decrease in resistance to Ehrlich tumor growth. 
On this basis, it would be reasonable to hypothesize also 
that the present data regarding both peritoneal macrophage 
activity and/or host resistance to Ehrlich tumor growth 
depend on the effects of the pesticide on HPA axis activ-
ity, particularly on blood corticosterone levels. An altered 
endocrine response to stress is well known to be linked to 
immune disorders/disease susceptibility (7,14,36). A de-
crease in cell-mediated immune function with a concomitant 
increase in susceptibility to cancer was reported in persons 
undergoing distressing life experiences (2-4) and also in 
stressed animals (4,7-9). 
Therefore, we suggest here that the effects of cyha-
lothrin in mice would be in overall agreement with data 
from other studies that have examined the link between 
HPA axis activation and host animal resistance to tumor 
growth (2,7-9,36). Although the present data do not permit 
additional comments, it seems relevant to point out that 
glucocorticoid hormones such as corticosterone modulate 
the profiles of Th1 and Th2 cytokines (37) and activate Toll-
like receptors and NF-κB gene expression (38). Cytokines 
play a relevant role in innate immunity (39) and NF-κB is a 
relevant transcription factor for macrophage activation (40). 
It should not be forgotten, however, that recent research in 
the field of psychoneuroimmunology suggests that there 
are several pathways beside HPA axis activation by which 
stress may affect immune function (1-3).
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